Genomics plc introduces MySTra AI, an AI platform that uses polygenic scores to improve disease risk prediction and support drug discovery and personalized medicine.
Genomics plc Launches MySTra AI to Advance Predictive Genetics with Polygenic Scores Read More »
ASUS introduced an AI healthcare ecosystem linking DuoScan ultrasound and VivoWatch 6 Plus with an AI agent platform for closed-loop, real-time clinical decisions.
ASUS Reveals AI Healthcare Ecosystem for Real-Time Clinical Care Read More »
A concise overview of Europe’s strategy for AI in healthcare, covering policy, market trends, ethical safeguards, implementation gaps and the road ahead.
Europe’s AI Healthcare Journey: Balancing Innovation, Ethics and Regulation Read More »
Discover how AI-driven functional imaging, including X-ray Velocimetry (XV), detects lung disease earlier than spirometry or CT and enables precision respiratory care for conditions like cystic fibrosis and asthma.
AI and Functional Lung Imaging: How X‑ray Velocimetry Is Shifting Respiratory Care Read More »
In this article, Dr Mike Roberts, Medical Advisor at Camgenium, draws on 15 years of experience in hospital risk management whilst serving in Medical Director roles.
Redefining Risk Management: AI’s Role in a Safer, Smarter Healthcare System Read More »
AI is already used in low- and middle-income countries, but limited compute and weak data sovereignty threaten equitable benefits. Practical steps for policymakers and funders.
AI in Global Health: The Hidden Infrastructure LMICs Need Read More »
London startup Perceptic raised $12M to build an AI operating system that unites fragmented pharma R&D workflows, speeding due diligence and clinical translation.
Perceptic’s AI Operating System Raises $12M to Unite Drug Discovery Read More »
How Europe is balancing AI-driven healthcare innovation with new regulations like the AI Act and EHDS, and what health systems need to adopt AI responsibly.
Europe’s AI Healthcare Journey: Innovation, Regulation, and Roadblocks Read More »
How AI is reshaping drug discovery and programmable therapeutics, why investors poured billions, and what scientific and data bottlenecks remain.
Lucis secured $20M Series A to expand its AI-backed preventive health platform that uses 110+ biomarkers, physician-reviewed insights, and proven clinical outcomes across Europe.
Lucis Raises $20M Series A to Scale AI-Driven Preventive Healthcare Across Europe Read More »
